Evaluation of Safety of Intralesional Cidofovir for Adjuvant Treatment of Recurrent Respiratory Papillomatosis

IMPORTANCE: The use of intralesional cidofovir injections for recurrent respiratory papillomatosis (RRP) remains controversial owing to concern regarding the risks of its use, including increased risk of dysplasia or carcinogenesis. OBJECTIVE: To describe the rates of dysplasia, development of malig...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JAMA Otolaryngol Head Neck Surg
Autores principales: Hoesli, Rebecca C., Thatcher, Aaron L., Hogikyan, Norman D., Kupfer, Robbi A.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7018395/
https://ncbi.nlm.nih.gov/pubmed/31895450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoto.2019.4029
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares